Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06103825 |
| Consolidated Lead Sponsor | Ignis Therapeutics (Suzhou) Limited |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 204 participants (ACTUAL) |
| Registered Start Date | 2023-08-01 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| China-Japan Friendship Hospital | Beijing, China | Open Hospital Dossier -> |
| Xuanwu Hospital Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| The First Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.